NEWS
Late Effects May Not Warrant Using Radiation to Treat Early-Stage Hodgkin Lymphoma
Patients with early-stage Hodgkin lymphoma who were treated with multidrug chemotherapy alone were more likely to be alive 12 years later than patients who received treatment that included radiation therapy, according to findings from a phase III clinical trial. More patients who received radiation therapy died of second cancers or other toxic late effects of their treatment, such as heart disease, than those who received chemotherapy alone, researchers reported Monday at the American Society of Hematology (ASH) annual scientific meeting in San Diego. The findings, which are the first long-term results from a randomized trial involving patients with early-stage Hodgkin lymphoma, also appeared online December 11 in the New England Journal of Medicine. Read more > >
Combination Therapy Shows Promise for Treating Advanced Breast Cancer
Researchers present updated results from a study of everolimus plus exemestaneMost Common Adult Muscular Dystrophy Linked to Increased Cancer Risk
Study indicates double the normal rate of cancer in two independent patient populationsTwo Drugs that Hit One Target Show Efficacy against Metastastic Breast Cancer
Adding pertuzumab to trastuzumab and chemotherapy improved progression-free survivalProstate Cancer Trials Show No Link between Androgen-Deprivation Therapy and Cardiac Death
Treatment is associated with lower risk of death from prostate cancer and all causes
COMMENTARY
mHealth Summit Keynote Address by Secretary Kathleen Sebelius
The Honorable Kathleen Sebelius, secretary of the Department of Health and Human Services, delivered the following remarks at the mHealth Summit on December 5 in Washington DC.
A Conversation with Dr. Barry Kramer about Cancer Prevention Research at NCI
Dr. Barry Kramer, the new director of NCI's Division of Cancer Prevention, talks about prevention and screening research.
A MESSAGE TO READERS
NCI Cancer Bulletin Publication Break
The NCI Cancer Bulletin will not be published on December 27. Our next issue will be published on January 10, when we resume our usual biweekly publication schedule. You'll find some of the important research news and feature stories we covered this year on our 2011 Editors' Picks list.
If you are not yet a subscriber, please enter your e-mail address in the box in the top right-hand corner to begin your free subscription.
IN DEPTH
Panel Encourages Broader Use of Surveillance in Some Men with Prostate Cancer
Report suggests removing the term "cancer" from low-risk disease
Institute of Medicine Releases Report on Breast Cancer and the Environment
Report urges further research, offers ways to potentially reduce breast cancer risk
Cancer Clinical Trials System Restructuring Moves Forward
Changes include consolidation, higher reimbursements, greater integration
Featured Clinical Trial: Comparing Postoperative Radiation Therapies for Brain Metastases
Which radiation therapy procedure will produce better outcomes for patients?
Cancer News Workshop Helps Latin American and U.S. Journalists Interpret Research Results
Scientists and journalists discussed how best to report cancer research news
UPDATES
Notes
- In Memoriam: Lloyd Old, Cancer Immunology Pioneer
- Barbara Rimer and Owen Witte to Join the President's Cancer Panel
- National Cancer Advisory Board Holds Final Meeting of 2011
- Toby Hecht Appointed Associate Director of Translational Research Program
- NCI Launches Text Message Service to Help Teens Quit Smoking
- Radiation Epidemiology and Dosimetry Course Available Online
- Funding Available to Support Collaborations between U.S. and Chinese Scientists
Selected articles from past issues of the NCI Cancer Bulletin are available in Spanish.
The NCI Cancer Bulletin is produced by the National Cancer Institute (NCI), which was established in 1937. Through basic, clinical, and population-based biomedical research and training, NCI conducts and supports research that will lead to a future in which we can identify the environmental and genetic causes of cancer, prevent cancer before it starts, identify cancers that do develop at the earliest stage, eliminate cancers through innovative treatment interventions, and biologically control those cancers that we cannot eliminate so they become manageable, chronic diseases.
For more information about cancer, call 1-800-4-CANCER or visit http://www.cancer.gov.
NCI Cancer Bulletin staff can be reached at ncicancerbulletin@mail.nih.gov.
